Firms
Theme

BAM

Brookfield Asset Management Ltd. · NYSE

News

7 latest

Zacks Investment Research

Brookfield (BAM) Upgraded to Buy: Here's What You Should Know

Brookfield Asset Management (BAM) has been upgraded to a Zacks Rank #2 (Buy) rating, reflecting upward trends in earnings estimates over the past three months. The upgrade positions the company in the top 20% of Zacks-covered stocks, suggesting potential for near-term stock price appreciation driven by improving business fundamentals and analyst sentiment.

The Motley Fool

3 High-Yield Financial Stocks to Buy in October

Despite elevated Treasury yields near 5.3%, three financial stocks remain attractive high-yield investments: Ares Capital (10% yield, rate-resistant BDC model), Brookfield Asset Management (4.5% yield, asset-light fee-based model), and Strategy's Strife preferred shares (10% fixed dividend, senior preferred stock backed by Bitcoin holdings).

Zacks Investment Research

RITM vs. BAM: Which Stock Is the Better Value Option?

A comparison of Rithm (RITM) and Brookfield Asset Management (BAM) for value investors shows RITM as the more attractive option. RITM has a Zacks Rank of #2 (Buy) with a forward P/E of 4.02 and Value grade of B, while BAM has a Zacks Rank of #3 (Hold) with a forward P/E of 24.09 and Value grade of F. RITM's superior valuation metrics and stronger estimate revision activity make it the preferred choice for value-focused investors.

Mentions BAM

The Motley Fool

Bloom Energy Stock Sinks Despite Record Revenue and a Stellar Outlook. Is It Time to Buy?

Bloom Energy delivered record Q3 results with 138% revenue growth and raised full-year 2026 guidance to $4.5 billion (122% growth), yet its stock plunged 30% in one month. The decline appears driven by negative free cash flow of $181 million in Q3, though the author argues this reflects necessary capacity expansion to meet exploding AI data center demand. With backlog growing faster than revenue and a $25 billion financing deal from Brookfield, the article suggests the selloff may present a buying opportunity.

Zacks Investment Research

American Express (AXP) Beats Q3 Earnings Estimates

American Express reported Q3 2026 earnings of $4.68 per share, beating consensus estimates of $4.47, but revenues slightly missed expectations at $20.06 billion. The stock has underperformed the S&P 500 by 24.1% year-to-date. With a Zacks Rank #3 (Hold) rating and the Financial - Miscellaneous Services industry in the bottom 28% of rankings, the stock is expected to perform in line with the market.

The Motley Fool

Bloom Energy vs. Vertiv: Which AI Infrastructure Stock Is the Better Buy After the Pullback?

Bloom Energy and Vertiv are two AI infrastructure plays that have recently pulled back. Bloom Energy focuses on fuel cell power generation for data centers, while Vertiv specializes in cooling systems.

GlobeNewswire Inc.

U.S. – Korea Framework Advances Deployment of Westinghouse Nuclear Technology in the United States

The U.S. Government and Republic of Korea announced a strategic framework agreement committing up to $120 billion to finance the construction of eight nuclear reactors in the U.S., including six Westinghouse AP1000 reactors and two Korean APR1400 reactors on federal sites. Korea will also make a cornerstone equity investment of 5-10% in Westinghouse, with Westinghouse receiving upfront payments and guaranteed scope of work.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $BAM · 0 threads

Sign in to post on $BAM

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev